Skip to main content
. 2018 Jan 8;2018(1):CD008074. doi: 10.1002/14651858.CD008074.pub2

Istikoglou 2010.

Trial name or title  
Methods Allocation: randomised.
Blindness: rater‐blind.
Duration: not stated.
Participants Diagnosis: psychosis.
N = 120.
Age: not stated.
Sex: not stated.
History: displaying agitation.
Exclusion: not stated.
Setting: patients with psychotic agitation presenting at emergency room of two Greek psychiatric departments ("Konstantopouleion" and "Asklepeion" General Hospitals, Athens).
Interventions 1. Aripiprazole: IM unknown dose.
2. Haloperidol: IM unknown dose.
Outcomes Global outcome: CGI‐I, QoL.
Mental state: YMRS, PANSS.
Adverse effects: AIMS, SAS.
Starting date  
Contact information  
Notes Conference proceeding, several data are not reported.

AIMS: Abnormal Involuntary Movement Scale
 CGI‐I: Clinical Global Impression ‐ Improvement
 IM: intramuscular
 PANSS: Positive And Negative Syndrome Scale
 QoL: Quality of Life
 SAS: Simpson Angus Scale
 YMRS: Young Mania Rating Scale